Recall Register

Food, drugs, devices › Siemens Medical Solutions USA, Inc

Device recall: CIOS ALPHA (Image-intensified fluoroscope x-ray system) Product Usage: The Cios Alpha is a mobile X-ray system designed

FDA enforcement event 73546 · Class II · initiated 16 Feb 2016 · status Terminated · terminated 8 Nov 2017

DeviceVoluntary: Firm initiated1 product recordMalvern, PA

Siemens Medical Solutions USA, Inc (Malvern, PA) initiated this device recall on 16 Feb 2016; FDA lists 1 product record under event 73546, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,232 device enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 8 Nov 2017. Initiation: voluntary: firm initiated. Siemens Medical Solutions USA, Inc has 400 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Siemens Medical Solutions USA, Inc, Malvern, PA.

Reason for recall

"Siemens found a defective part in their production line which could increase risk of an electrical shock for service personnel when working inside the device during system maintenance. The risk of an electrical shock is only present when a service technician ignores several steps listed in the service manual as precautionary actions during device maintenance."

Distribution

"US Nationwide Distributed in the states of AR, CA, NE and UT"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1281-2016CIOS ALPHA (Image-intensified fluoroscope x-ray system) Product Usage: The Cios Alpha is a mobile X-ray system designed to provide X-ray imaging of the anatomical structures of patient during clinical applications. Clinical applications may include but are not limited to: interventional fluoroscopic,…4 unitsClass IITerminated6 Apr 2016

Context

91%of 2016 device events are Class II1,232 events that year
1product record in this eventfirm median: 1
400events on this register for the firm

Other enforcement events for Siemens Medical Solutions USA, Inc

InitiatedProduct (first record)TypeClassRecords
8 Jun 2026ARTIS icono ceiling. Model Number: 11328100.DeviceClass II1
20 May 2026ARTIS icono biplane. Model Number: 11327600.DeviceClass II3
12 Mar 2026ARTIS Pheno VE30A and VE40A, Model 10849000DeviceClass II1
10 Mar 2026ARTIS pheno and ARTIS Icono biplane, floor and ceiling. Model Numbers 10849000, 11327600, 11328100, 11327700.DeviceClass II1
9 Mar 2026ARTIS pheno, Model 10849000. interventional fluoroscopic x-ray systemDeviceClass II2
29 Dec 2025Interventional Fluoroscopic X-Ray System: LUMINOS Q.namix R; Siemens Material Number (SMN): 11574002; With Software VersDeviceClass II2
19 Dec 2025SOMATOM X.ceed Software applications: syngo.CT Brain Quantification syngo.CT Vessel Hyperdensities syngo.CT ASPECTSDeviceClass II4
5 Dec 2025LUMINOS Lotus Max, Model 11574100 and Luminos dRF Max, Model 10762471DeviceClass II1
24 Oct 2025MAMMOMAT Revelation;DeviceClass II3
1 Oct 2025MAGNETOM Cima.X Upgrade. Model Number: 11689304.DeviceClass I1

All 400 events for Siemens Medical Solutions USA, Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Siemens found a defective part in their production line which could increase risk of an electrical shock for service personnel when working inside the device during system maintenance. The risk of an electrical shock is only present when a service technician ignores several steps listed in the service manual as precautionary actions during device maintenance."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide Distributed in the states of AR, CA, NE and UT"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 8 Nov 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.